Picture of Stayble Therapeutics AB logo

STABL Stayble Therapeutics AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Stayble Therapeutics Gets Approved Patent In South Africa For Treatment Of Disc Herniation

Sept 5 (Reuters) - Stayble Therapeutics AB  STABL.ST :
    * RECEIVES ITS FIRST APPROVED PATENT FOR THE TREATMENT OF
DISC
HERNIATION
    * SOUTH AFRICAN PATENT OFFICE AS FIRST COUNTRY TO HAVE
APPROVED
CO'S PATENT TREATMENT OF HERNIATED DISC WITH STA363
    * PATENT PROVIDES PROTECTION UNTIL 2040

Source text for Eikon:  ID:nWkr48CtDd 
Further company coverage:  STABL.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Stayble Therapeutics AB

See all news